September 9, 2021 Comments Off on New patent for Allergan Holdings drug VIBERZI Posted in: Patent Added Annual Drug Patent Expirations for VIBERZI Viberzi is a drug marketed by Allergan Holdings and is included in one NDA. It is available from one supplier. There are fifteen patents…
The post New patent for Allergan Holdings drug VIBERZI appeared first o…
September 9, 2021 Comments Off on New patent expiration for Gilead drug EMTRIVA Posted in: Uncategorized
Annual Drug Patent Expirations for EMTRIVA Emtriva is a drug marketed by Gilead and is included in two NDAs. It is available from two suppliers. There are two patents protecting…
The post New patent expiration for Gilead drug EMTRIVA appeared first on …
